Health Condition 1: null- Pediatric Irritable Bowel syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Criteria of Pediatric IBS ROME 4
Exclusion criteria
Exclusion criteria: Children with IBS already on drug therapy or suffering from chronic diseases including, cardiac, renal and hepatic, failure to thrive, bronchial asthma, prior GI surgeries, malignancies, celiac disease, inflammatory bowel disease, cystic fibrosis, anatomical malformations of the gut, immune deficiencies, hypothyroidism, neurological and muscle diseases, and anatomical causes of bowel dysfunction will ruled out by clinical, laboratorial and radiological investigations. Child not on antibiotic therapy for atleast 4 weeks prior to enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom response to Psyllium VERSUS placebo as per IBS Severity scoring systmemTimepoint: symptom response after 4 weeks of starting medications | — |
Secondary
| Measure | Time frame |
|---|---|
| IL 6 and IL 10 levels at baseline and 4 weeks post intervention in the two drug limbsTimepoint: 4 WEEKS;Small intestinal bacterial overgrowth and its response to therapyTimepoint: 4 weeks | — |
Countries
India
Contacts
PGIMER, Chandigarh